Antibody Engineering and Recombinant Protein Biotechnology Unit

Aims to evaluate new opportunities to immunotherapeutic approaches using recombinant antibody derivatives. Includes information on the clinical use of antibodies and bispecific antibodies, as well as how to make the latter. Based at the Department of Molecular Biomedical Research, University of Ghent, Belgium.